Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Berrino

Showing results (21-30 of 242) with videos related to

Pageof 25
Sort By:
Patient Preference and Adherence|July 26, 2017
"Open mesh" or "strictly selected population" recruitment? The experience of the randomized controlled MeMeMe trialMauro Cortellini, Franco Berrino, Patrizia Pasanisi
Breast Cancer Research and Treatment|March 3, 2007
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyAgnès Fournier, Franco Berrino, Françoise Clavel-Chapelon
Epidemiologia E Prevenzione|February 5, 2024
COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian ProvinceFranco Berrino, Alberto Donzelli, Paolo Bellavite, et al.
EXCLI Journal|February 2, 2026
Comment to "COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province"Giovanni M Malatesta, Marco Alessandria, Franco Berrino, et al.
Microorganisms|July 27, 2024
A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian ProvinceMarco Alessandria, Giovanni M Malatesta, Franco Berrino, et al.
EXCLI Journal|May 7, 2026
Reply to the letter to the editor by Manzoli, Acuti Martelucci and Flacco (doi: 10.17179/excli2025-9176)Marco Alessandria, Franco Berrino, Giovanni M Malatesta, et al.
Epidemiologia E Prevenzione|November 12, 2015
[DianaWeb: a demonstration project to improve breast cancer prognosis through lifestyles]Anna Villarini, Milena Villarini, Giuliana Gargano, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 24, 2005
Progestins and progesterone in hormone replacement therapy and the risk of breast cancerCarlo Campagnoli, Françoise Clavel-Chapelon, Rudolf Kaaks, et al.
International Journal of Cancer|November 20, 2004
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohortAgnès Fournier, Franco Berrino, Elio Riboli, et al.
Tumori|September 29, 2007
Strategies for cancer control in ItalyAndrea Micheli, Franco Berrino, Eugenio Paci, et al.
Pageof 25

Showing results (21-30 of 242) with videos related to

Sort By:
Pageof 25
Patient Preference and Adherence|July 26, 2017
"Open mesh" or "strictly selected population" recruitment? The experience of the randomized controlled MeMeMe trialMauro Cortellini, Franco Berrino, Patrizia Pasanisi
Breast Cancer Research and Treatment|March 3, 2007
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyAgnès Fournier, Franco Berrino, Françoise Clavel-Chapelon
Epidemiologia E Prevenzione|February 5, 2024
COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian ProvinceFranco Berrino, Alberto Donzelli, Paolo Bellavite, et al.
EXCLI Journal|February 2, 2026
Comment to "COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province"Giovanni M Malatesta, Marco Alessandria, Franco Berrino, et al.
Microorganisms|July 27, 2024
A Critical Analysis of All-Cause Deaths during COVID-19 Vaccination in an Italian ProvinceMarco Alessandria, Giovanni M Malatesta, Franco Berrino, et al.
EXCLI Journal|May 7, 2026
Reply to the letter to the editor by Manzoli, Acuti Martelucci and Flacco (doi: 10.17179/excli2025-9176)Marco Alessandria, Franco Berrino, Giovanni M Malatesta, et al.
Epidemiologia E Prevenzione|November 12, 2015
[DianaWeb: a demonstration project to improve breast cancer prognosis through lifestyles]Anna Villarini, Milena Villarini, Giuliana Gargano, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 24, 2005
Progestins and progesterone in hormone replacement therapy and the risk of breast cancerCarlo Campagnoli, Françoise Clavel-Chapelon, Rudolf Kaaks, et al.
International Journal of Cancer|November 20, 2004
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohortAgnès Fournier, Franco Berrino, Elio Riboli, et al.
Tumori|September 29, 2007
Strategies for cancer control in ItalyAndrea Micheli, Franco Berrino, Eugenio Paci, et al.
Pageof 25